These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18594872)

  • 21. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
    Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
    Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?
    Cox VC; Ensom MH
    Ther Drug Monit; 2003 Apr; 25(2):137-57. PubMed ID: 12657908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.
    Kuypers DR; de Jonge H; Naesens M; de Loor H; Halewijck E; Dekens M; Vanrenterghem Y
    Clin Ther; 2008 Apr; 30(4):673-83. PubMed ID: 18498916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
    Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
    Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
    Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
    Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma.
    Westley IS; Sallustio BC; Morris RG
    Clin Biochem; 2005 Sep; 38(9):824-9. PubMed ID: 15963486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an Abbreviated Mycophenolic Acid Area Under the Time-Concentration Curve for Renal Transplant Patients Under Enteric-Coated Mycophenolate Sodium: A Comparison With Critical Analysis of Available Equations.
    David-Neto E; Triboni AH; Ramos F; Agena F; Romano P
    Ther Drug Monit; 2018 Aug; 40(4):411-416. PubMed ID: 29746396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome.
    Sobiak J; Resztak M; Chrzanowska M; Zachwieja J; Ostalska-Nowicka D
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.
    Zahr N; Amoura Z; Debord J; Hulot JS; Saint-Marcoux F; Marquet P; Piette JC; Lechat P
    Clin Pharmacokinet; 2008; 47(4):277-84. PubMed ID: 18336056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis.
    Llinares-Tello F; Hernández-Prats C; Muñoz-Ruiz C; Selva-Otaolaurruchi J; Ordovás-Baines JP
    J Clin Pharm Ther; 2004 Feb; 29(1):53-8. PubMed ID: 14748898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a CE method for the determination of mycophenolic acid in human plasma: a comparison with HPLC.
    Carlucci F; Anzini M; Rovini M; Cattaneo D; Merlini S; Tabucchi A
    Electrophoresis; 2007 Nov; 28(21):3908-14. PubMed ID: 17922503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring.
    Vogl M; Weigel G; Seebacher G; Griesmacher A; Laufer G; Müller MM
    Ther Drug Monit; 1999 Dec; 21(6):638-43. PubMed ID: 10604825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation.
    David-Neto E; Pereira Araujo LM; Sumita NM; Mendes ME; Ribeiro Castro MC; Alves CF; Kakehashi E; Romano P; Yagyu EM; Queiroga M; Nahas WC; Ianhez LE
    Pediatr Nephrol; 2003 Mar; 18(3):266-72. PubMed ID: 12644921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients.
    Zicheng Y; Peijun Z; Da X; Xianghui W; Hongzhuan C
    Br J Clin Pharmacol; 2006 Oct; 62(4):446-52. PubMed ID: 16995865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children.
    Zeng L; Nath CE; Shaw PJ; Earl JW; McLachlan AJ
    Biomed Chromatogr; 2009 Jan; 23(1):92-100. PubMed ID: 18823076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
    Brunet M; Martorell J; Oppenheimer F; Vilardell J; Millán O; Carrillo M; Rojo I; Corbella J
    Transpl Int; 2000; 13 Suppl 1():S301-5. PubMed ID: 11112019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range.
    Tredger JM; Brown NW; Adams J; Gonde CE; Dhawan A; Rela M; Heaton N
    Liver Transpl; 2004 Apr; 10(4):492-502. PubMed ID: 15048791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation.
    Brunet M; Oppenheimer F; Martorell J; Vilardell J; Carreño MC; Carrillo M; Corbella J
    Transplant Proc; 1999 Sep; 31(6):2275-6. PubMed ID: 10500574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.